Bio-Rad Laboratories Inc. (BUWA)
Summary
BUWA Chart
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
BIO's 19.1% monthly rally is backed by digital PCR gains and steadier diagnostics, but weak Life Science demand and a rich valuation loom.
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Bio-Rad Laboratories Inc. (BUWA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Bio-Rad Laboratories Inc. ever had a stock split?
Bio-Rad Laboratories Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Norman D. Schwartz CEO | XMUN Exchange | US0905722072 ISIN |
| US Country | 7,450 Employees | - Last Dividend | 8 Mar 2002 Last Split | - IPO Date |
Overview
Bio-Rad Laboratories, Inc., founded in 1952 and based in Hercules, California, is a prominent provider of life science research and clinical diagnostic products globally, serving customers in the United States, Europe, Asia, Canada, and Latin America. The company operates in two key segments: Life Science and Clinical Diagnostics. With a strong commitment to innovation and quality, Bio-Rad develops, manufactures, and distributes a wide range of instruments, systems, reagents, and consumables designed to advance scientific understanding and improve healthcare outcomes. The firm distributes its offerings through a direct sales force, alongside a network of distributors, agents, brokers, and resellers, ensuring broad and effective market reach.
Products and Services
Bio-Rad Laboratories, Inc. offers a vast array of products and services tailored to meet the needs of various markets, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, as well as clinical diagnostics.
- Life Science Research Products:
These include instruments, systems, reagents, and consumables for the separation, purification, characterization, and quantitation of biological materials like cells, proteins, and nucleic acids. These products support critical research areas in proteomics and genomics, empowering scientists to make groundbreaking discoveries in biology and medicine.
- Clinical Diagnostics Products:
Bio-Rad offers an extensive range of test systems, informatics systems, test kits, and specialized quality controls. These are designed for application in various settings including hospitals, diagnostic reference labs, transfusion services, and physician office laboratories. The clinical diagnostics segment focuses on providing accurate and reliable tools for the diagnoses of diseases and the monitoring of treatment efficacy.
- Biopharmaceutical Production Supplies:
This range supports the production of biopharmaceuticals with a focus on the purification and analysis of biological materials. Bio-Rad's products in this category are essential for ensuring the safety and efficacy of biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins.
- Food Safety Testing Products:
Bio-Rad also provides robust solutions for testing the safety of food products. These include reagents, instruments, and systems that help detect potentially harmful contaminants in food, ensuring compliance with international food safety standards and protecting public health.
